Xencor (XNCR)- Paul A. Foster, Chief Medical Officer, sold 1,183 shares at $17.01. Foster still owns 2,419 shares of XNCR. Edgardo Baracchini Jr., sold 1,250 shares at $15.10. Bararcchini still owns 4,528 shares of XNCR.
Bristol-Myers Squibb (BMY)- Lamberto Andreotti, Director, sold 23,200 shares in two separate transactions. Andreotti sold 13,400 shares at $71.67; and 9,800 shares at $72.79. Andreotti still owns 392,194 shares of BMY.
FibroGen (FGEN)- Thomas B. Neff, CEO, sold 27,000 shares in two separate transactions. Neff sold 13,500 shares at $15.87; and 13,500 shares at $16.17. Neff still owns 3,426,164 shares of FGEN.
Vertex Pharmaceuticals (VRTX)- Joshua S. Boger, Director, sold 5,130 shares at $84.82. The total value of the transaction was $435,107. Boger still owns 268,225 shares of VRTX.
Eli Lilly (LLY)- Lilly Endowment Inc., a 10% owner, sold 220,000 shares at $77.86. The total value of the transaction was approximately $17.13 million. Lilly Endowment still owns 126,870,804 shares of LLY.